San Francisco, CA, United States of America

Kaijie Zheng


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kaijie Zheng: Innovator in CRISPR Technology

Introduction

Kaijie Zheng is a prominent inventor based in San Francisco, CA, known for his contributions to the field of genetic engineering. His work primarily focuses on the optimization of CRISPR-Cas systems, which have significant implications for gene editing and biotechnology.

Latest Patents

Zheng holds a patent titled "Engineering and optimization of systems, methods, enzymes and guide scaffolds of CAS9 orthologs and variants for sequence manipulation." This invention provides systems, methods, and compositions for altering the expression of target gene sequences and related gene products. It includes structural information on the Cas protein of the CRISPR-Cas system and details the generation of modified components of the CRISPR complex. The patent also outlines methods for directing CRISPR complex formation in eukaryotic cells and utilizing the CRISPR-Cas system effectively. The present invention emphasizes optimized functional CRISPR-Cas enzyme systems, including engineered new guide architectures and enzymes.

Career Highlights

Throughout his career, Kaijie Zheng has worked with prestigious institutions, including the Broad Institute, Inc. and the Massachusetts Institute of Technology. His innovative research has contributed to advancements in genetic engineering and biotechnology.

Collaborations

Zheng has collaborated with notable scientists in the field, including Feng Zhang and Winston X Yan. These partnerships have furthered the development of CRISPR technology and its applications.

Conclusion

Kaijie Zheng's work in optimizing CRISPR-Cas systems marks him as a significant figure in the field of genetic engineering. His contributions continue to influence advancements in biotechnology and gene editing.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…